MOB4 and cancer: Supporting this idea, it was shown that, unlike MOB1 or MOB2, MOB3 inhibits LATS1/2 signaling within the Hippo pathway and allows for continued proliferation of cells even after OIS (Dutchak et al., 2022), potentially contributing to cancer progression.